Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1980 1
1981 1
1982 1
1984 2
1985 2
1986 2
1987 2
1988 7
1989 13
1990 7
1991 4
1992 6
1993 6
1994 7
1995 3
1996 7
1997 10
1998 5
1999 3
2000 9
2001 7
2002 2
2003 2
2004 13
2005 8
2006 7
2007 12
2008 8
2009 11
2010 8
2011 10
2012 10
2013 11
2014 7
2015 4
2016 9
2017 6
2018 4
2019 5
2020 5
2021 3
2022 5
2023 3
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

249 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for gress re[au]
Your search for Grese RE[au] retrieved no results
Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma.
Brudno JN, Lam N, Vanasse D, Shen YW, Rose JJ, Rossi J, Xue A, Bot A, Scholler N, Mikkilineni L, Roschewski M, Dean R, Cachau R, Youkharibache P, Patel R, Hansen B, Stroncek DF, Rosenberg SA, Gress RE, Kochenderfer JN. Brudno JN, et al. Among authors: gress re. Nat Med. 2020 Feb;26(2):270-280. doi: 10.1038/s41591-019-0737-3. Epub 2020 Jan 20. Nat Med. 2020. PMID: 31959992 Free PMC article. Clinical Trial.
Interleukin-7 immunotherapy.
Sportès C, Gress RE. Sportès C, et al. Among authors: gress re. Adv Exp Med Biol. 2007;601:321-33. doi: 10.1007/978-0-387-72005-0_35. Adv Exp Med Biol. 2007. PMID: 17713021 Review.
High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention.
Holtzman NG, Curtis LM, Salit RB, Shaffer BC, Pirsl F, Ostojic A, Steinberg SM, Schulz E, Wilder JS, Hughes TE, Rose J, Memon S, Korngold R, Gea-Banacloche JC, Fowler DH, Hakim FT, Gress RE, Bishop MR, Pavletic SZ. Holtzman NG, et al. Among authors: gress re. Blood Adv. 2024 Aug 27;8(16):4294-4310. doi: 10.1182/bloodadvances.2023010973. Blood Adv. 2024. PMID: 38669315 Free PMC article. Clinical Trial.
Aging, immunity and cancer.
Hakim FT, Flomerfelt FA, Boyiadzis M, Gress RE. Hakim FT, et al. Among authors: gress re. Curr Opin Immunol. 2004 Apr;16(2):151-6. doi: 10.1016/j.coi.2004.01.009. Curr Opin Immunol. 2004. PMID: 15023406 Review.
Lymphoid reconstruction and vaccines.
Gress RE, Komanduri KV, Einsele H, Cooper LJ. Gress RE, et al. Biol Blood Marrow Transplant. 2007 Jan;13(1 Suppl 1):17-22. doi: 10.1016/j.bbmt.2006.10.012. Biol Blood Marrow Transplant. 2007. PMID: 17222765 Free PMC article. Review.
Microbial ligand-independent regulation of lymphopoiesis by NOD1.
Iwamura C, Ohnuki H, Flomerfelt FA, Zheng L, Carletti A, Wakashin H, Mikami Y, Brooks SR, Kanno Y, Gress RE, Tosato G, Nakayama T, O'Shea JJ, Sher A, Jankovic D. Iwamura C, et al. Among authors: gress re. Nat Immunol. 2023 Dec;24(12):2080-2090. doi: 10.1038/s41590-023-01668-x. Epub 2023 Nov 13. Nat Immunol. 2023. PMID: 37957354
249 results